RxDoctor Payments Data

Diane Dockery

Family · Murphy, NCNPI 1952186827

Payments from drug & device makers

$1,215in general payments, 2019–2025

Across 76 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$459
  • Amgen$121
  • Lilly USA, LLC$116
  • Novo Nordisk$109
  • GSK$64
  • Otsuka America Pharmaceutical, Inc.$62
  • plus $285 from 9 others

What the payments were for

  • Food & beverage$1,215100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,215 in reported general payments places this provider in the 70th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$781
Medicare patients
32
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$55,075
MounjaroTirzepatide43$48,904
FarxigaDapagliflozin Propanediol41$31,678
JardianceEmpagliflozin32$28,176
EliquisApixaban30$23,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$15,115
Tresiba Flextouch U-100Insulin Degludec11$5,870
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,360
Gabapentin131$1,686
Albuterol Sulfate HfaAlbuterol Sulfate52$1,535
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$1,224
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$973
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$848
Atomoxetine Hcl11$709
Levothyroxine Sodium97$523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$109$55,07544 claims
Lilly USA, LLCMounjaro$116$48,90443 claims
AstraZenecaFarxiga$38$31,67841 claims
PfizerEliquis$16$23,03630 claims
GSKTrelegy Ellipta, Anoro Ellipta$64$19,47531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,522 family providers in North Carolina.

Other family in Murphy

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →